跳至主要内容
临床试验/NCT02959840
NCT02959840已完成4 期

Is Intra-operative Acupuncture Point P6 Stimulation as Effective as Traditional Pharmacotherapy in Reducing Nausea and Vomiting During Cesarean Section With Regional Anesthesia?

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
180
试验地点
1
主要终点
Nausea

研究概览

简要总结

The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.

详细描述

The design of the study consists of the randomization of subjects undergoing cesarean section with regional anesthesia in one of three groups. The study is not blinded; as the participants will know which method they are being treated with because of the difference in site and nature of the acupuncture point P6 stimulation. The randomization of patients will be done by a computer to avoid bias before the informed consent form (ICF) is signed by the patients. The computer will generate three sets of random numbers for the three groups. Once the consent form is signed, the investigator will allocate the patients serially to the groups having those numbers . The randomization will be created before the study begins and will assign 180 subjects into one of the three groups to receive the treatment as follows:

Group I (n=60): Will be the control group patients and will not be given traditional medical therapy nor will receive acupuncture point P6 stimulation prior to administration of the standardized epidural anesthesia, as outlined below.

Group II (n=60): Will receive traditional medical management, consisting of 10 mg metoclopramide IV and 8 mg of ondansetron IV immediately prior to administration of the standardized regional anesthesia, as outlined below.

Group III (n=60): Will receive acupuncture point P6 stimulation. This is a stimulation of the chi channel at the master of the heart (MH8 position) at the small depression of the volar surface of the distal right forearm just above the crest of the wrist. The device will be put on the patients in the operating room prior to administration of the regional anesthesia and will be removed after the cesarean section is complete. The device will be removed from the patient in the operating room, before the patient is transported to the recovery room. Patients will receive continuous stimulation at a level that is comfortable for the patient prior to administration of the standardized regional anesthesia, as outlined below.

After the subjects have been randomly assigned to one of the three groups, subjects will receive the standardized regional anesthesia consisting of 2 milliliters (10 milligrams) of 0.5% bupivicaine and 20 micrograms of fentanyl and 100 micrograms of epinephrine. Patients will offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea every experienced).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female subjects ages 18 to 45
  • Subjects with American Society of Anesthesiologists (ASA) Class I or II
  • Subjects with elective primary or repeat cesarean delivery
  • Subjects who receive combined spinal epidural anesthesia
  • English and non-English speaking subjects will be included in the study

排除标准

  • Female subjects <18 years of age
  • Subjects requiring emergent cesarean delivery
  • History of placenta accrete
  • Multiple gestation pregnancy
  • ASA status III or higher
  • Current history of pregnancy induced hypertension, pre-eclampsia, or eclampsia
  • History of any chronic medication use (other than prenatal vitamins), including inhaler medications
  • Current urinary tract infection, pneumonia, or otitis media

研究组 & 干预措施

Metoclopramide, Ondansetron

Active Comparator

10 mg Metoclopramide IV and 8 mg of Ondansetron IV immediately prior to administration of the standardized regional anesthesia

干预措施: Metoclopramide (Drug)

Metoclopramide, Ondansetron

Active Comparator

10 mg Metoclopramide IV and 8 mg of Ondansetron IV immediately prior to administration of the standardized regional anesthesia

干预措施: Ondansetron (Drug)

Acupressure Point P6 stimulator

Experimental

Acupuncture point P6 stimulation. This is a stimulation of the chi channel at the master of the heart (MH8 position) at the small depression of the volar surface of the distal right forearm just above the crest of the wrist. The device will be put on the patients in the operating room prior to administration of the regional anesthesia and will be removed after the cesarean section is complete.

干预措施: Acupressure Point P6 stimulator (Device)

结局指标

主要结局

Nausea

时间窗: During the surgical procedure

The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea at any point during the surgical procedure in each group.

Vomiting

时间窗: During the surgical procedure

The investigators will perform objective assessments of whether or not the patients have vomited during the procedure. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group.

次要结局

  • Nausea During Stage I (After the Administration of CSE and Until Eversion of the Uterus)(During the surgical procedure)
  • Nausea During Stage II (After Eversion of the Uterus and Until Replacement of the Uterus)(During the surgical procedure)
  • Nausea During Stage III (After Replacement of the Uterus and to the Next 15 Minutes)(During the surgical procedure)
  • Nausea During Stage IV (the Rest of the Time Until Arrival at PACU)(During the surgical procedure)
  • Vomiting During Stage I (After the Administration of CSE and Until Eversion of the Uterus)(During the surgical procedure)
  • Vomiting During Stage II (After Eversion of the Uterus and Until Replacement of the Uterus)(During the surgical procedure)
  • Vomiting During Stage III (After Replacement of the Uterus and to the Next 15 Minutes)(During the surgical procedure)
  • Vomiting During Stage IV (the Rest of the Time Until Arrival at PACU)(During the surgical procedure)
  • Satisfaction of Anti-emetic Treatment(During the surgical procedure)
  • Overall Anesthetic Care Satisfaction(During the surgical procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaul Cohen, M.D.

Director of Obstetric Anesthesia

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验